Mar. 28, 2012—Vanderbilt Heart recently used a newly approved medical device to open narrowed coronary arteries, even in heart disease patients who also have diabetes.
Mar. 21, 2012—Using social media to communicate and educate about diabetes is the topic of a lunchtime lecture on March 23. Shelagh Mulvaney, assistant professor of nursing, biomedical informatics and pediatrics at Vanderbilt, will discuss “The Rules of Engagement: Using Social Technologies to Enhance Diabetes Education” at noon Friday, March 23, in Preston Research Building, Room 206....
Mar. 21, 2012—Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.
Mar. 2, 2012—A new study finds long-lasting reversal of diabetes is possible without insulin through transplantation of brown fat tissue.
Jan. 20, 2012—A strain of mutant mice provide a novel model for studying glucose intolerance and gestational diabetes during pregnancy and suggest that certain molecules may be useful for therapeutic applications.
Jan. 5, 2012—Loren Kirkpatrick has been enrolled in the Diabetes Control and Complications Trial (DCCT) at Vanderbilt’s Diabetes Center for nearly half of her adult life. Diagnosed with type 1 diabetes in 1982 at age 34, Kirkpatrick enrolled as the study’s first patient in 1983. Now Kirkpatrick has become the symbol of what Vanderbilt researchers hope is...
Nov. 18, 2011—Fatty liver, a reversible condition of fat accumulation in liver cells, can result from excessive alcohol consumption, obesity, type 2 diabetes, or metabolic disorders. Exercise can reverse this process, but the mechanisms underlying this effect are not clear. Because exercise is known to stimulate the action of glucagon (a hormone that raises blood glucose levels)...
Oct. 21, 2011—A growth factor may help grow transplantation-quality pancreas cells for treating diabetes.
Oct. 21, 2011—The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home.
Sep. 15, 2011—A new study indicates that patients with high-grade glioma brain tumors who have preexisting type 2 diabetes or obesity have poorer outcomes, and is the first to use the Vanderbilt Brain Tumor Center Clinical Database to report a novel clinical finding.
Sep. 12, 2011—Vanderbilt leads the nation in a breakthrough drug study that may prevent type-1 diabetes! Plus, how studying the brain could impact criminal law. And a special tribute on the anniversary of 9/11.
Sep. 12, 2011—Video: Watch this story about a breakthrough drug study that may prevent type-1 diabetes.